covid-19 vaccine
Paid Covid-19 booster vaccine for all adults at private centres
All those aged 18 or above and have completed nine months after the administration of the second dose, will be eligible for the booster dose
DCGI grants restricted EUA to Covid jab Corbevax for 12-18 age group
the government has not taken a decision yet on vaccinating those aged below 15 years
Nasal vaccine might help fight new COVID-19 variants: Study
The research has been published in the 'Science Immunology Journal'
Half of India's adult population fully vaccinated against COVID-19
The government then decided to expand its vaccination drive by allowing everyone above 18 to be vaccinated from May 1
CDSCO seeks more data from SII, says Covovax not yet approved in country of origin
The DCGI office had granted SII permission to manufacture and stock Covovax on May 17
WHO grants emergency use licence to Bharat Biotech's Covaxin
CDSCO has approved the extension of shelf life of Covaxin up to 12 months from the date of manufacture
Covid booster dose effective in reducing severe disease outcomes: Lancet study
Individuals were assigned to each group dynamically based on their changing vaccination status
Bharat Biotech's US partner Ocugen files request with FDA for Covaxin trials
Ocugen has already sought regulatory approval from Health Canada for Covaxin to be used in that country
BE hopes to roll out COVID-19 vaccine Corbevax by November-end
Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is ndergoing phase 2/3 clinical trials on adults
Cadila Healthcare gets DCGI nod to conduct phase 3 trials for two-dose COVID vaccine
The company has got the permission for conduct of phase III trials for two-dose Covid vaccine, Cadila Healthcare said in a regulatory filing